MILPREM-200 Drug Patent Profile
✉ Email this page to a colleague
When do Milprem-200 patents expire, and when can generic versions of Milprem-200 launch?
Milprem-200 is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.
The generic ingredient in MILPREM-200 is estrogens, conjugated; meprobamate. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated; meprobamate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MILPREM-200?
- What are the global sales for MILPREM-200?
- What is Average Wholesale Price for MILPREM-200?
Summary for MILPREM-200
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 27 |
| DailyMed Link: | MILPREM-200 at DailyMed |
US Patents and Regulatory Information for MILPREM-200
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medpointe Pharm Hlc | MILPREM-200 | estrogens, conjugated; meprobamate | TABLET;ORAL | 011045-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
